Epic Update : Dr Reddys Laboratories

Dr Reddys Laboratories has received US Food and Drug Administration (FDA) approval for Azacitidine Injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection) on September 16, 2013. The launch of product in the market is planned in the near-term.



http://www.epicresearch.co/



0731-664-2300

Posted in: Indian Market Tips